S&P 500   4,207.27 (-0.07%)
DOW   33,336.67 (+0.08%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
S&P 500   4,207.27 (-0.07%)
DOW   33,336.67 (+0.08%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
S&P 500   4,207.27 (-0.07%)
DOW   33,336.67 (+0.08%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
S&P 500   4,207.27 (-0.07%)
DOW   33,336.67 (+0.08%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)

Encompass Health - EHC Stock Forecast, Price & News

$52.87
-0.18 (-0.34%)
(As of 08/11/2022 12:00 AM ET)
Add
Compare
Today's Range
$52.70
$53.90
50-Day Range
$46.54
$65.59
52-Week Range
$44.33
$81.45
Volume
403,364 shs
Average Volume
872,987 shs
Market Capitalization
$5.28 billion
P/E Ratio
16.17
Dividend Yield
2.11%
Price Target
$73.60

Encompass Health MarketRank™ Forecast

Analyst Rating
Buy
3.11 Rating Score
Upside/​Downside
35.6% Upside
$71.70 Price Target
Short Interest
Healthy
2.48% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.68
Upright™ Environmental Score
News Sentiment
-0.47mentions of Encompass Health in the last 14 days
Based on 29 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
32.03%
From $2.56 to $3.38 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.29 out of 5 stars

Medical Sector

5th out of 1,112 stocks

Hospitals Industry

1st out of 3 stocks

EHC stock logo

About Encompass Health (NYSE:EHC) Stock

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

Encompass Health Stock Down 0.3 %

EHC Stock traded down $0.18 on Thursday, reaching $52.87. 403,364 shares of the company traded hands, compared to its average volume of 872,968. Encompass Health has a one year low of $44.33 and a one year high of $81.45. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.24 and a quick ratio of 1.24. The company has a market cap of $5.28 billion, a P/E ratio of 16.28, a price-to-earnings-growth ratio of 2.75 and a beta of 0.91. The firm has a fifty day simple moving average of $53.13 and a 200-day simple moving average of $62.51.

Encompass Health (NYSE:EHC - Get Rating) last posted its quarterly earnings data on Monday, August 1st. The company reported $0.89 earnings per share for the quarter, missing analysts' consensus estimates of $0.97 by ($0.08). Encompass Health had a net margin of 6.22% and a return on equity of 16.20%. The company had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.34 billion. During the same period last year, the business earned $1.17 EPS. The firm's quarterly revenue was up 3.3% on a year-over-year basis. Research analysts anticipate that Encompass Health will post 2.56 earnings per share for the current year.

Encompass Health Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Monday, October 3rd will be paid a dividend of $0.15 per share. The ex-dividend date is Friday, September 30th. This represents a $0.60 annualized dividend and a yield of 1.13%. Encompass Health's dividend payout ratio is 34.25%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on EHC. Credit Suisse Group lowered their price objective on Encompass Health to $63.00 in a research report on Tuesday. Barclays reduced their price objective on Encompass Health from $80.00 to $63.00 and set an "overweight" rating on the stock in a research note on Thursday, August 4th. Raymond James reduced their price objective on Encompass Health from $70.00 to $65.00 and set a "strong-buy" rating on the stock in a research note on Thursday, August 4th. BMO Capital Markets cut their price target on Encompass Health from $83.00 to $65.00 and set an "outperform" rating on the stock in a research note on Thursday, August 4th. Finally, StockNews.com downgraded Encompass Health from a "buy" rating to a "hold" rating in a research report on Wednesday, August 3rd. One equities research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $71.70.

Receive EHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

EHC Stock News Headlines

Encompass Health (EHC) Up 4.7% Despite Q2 Earnings Miss
Encompass Health (NYSE:EHC) Downgraded by StockNews.com
Encompass Health (NYSE:EHC) Price Target Cut to $62.00
Analysts Set Encompass Health Co. (NYSE:EHC) PT at $79.56
Encompass Health (EHC) Set to Announce Earnings on Monday
5 Healthcare Stocks to Beat a Recession
See More Headlines
Receive EHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

EHC Company Calendar

Ex-Dividend for 7/20 Dividend
7/12/2022
Dividend Payable
7/20/2022
Last Earnings
8/01/2022
Today
8/11/2022
Next Earnings (Estimated)
10/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Hospitals
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
42192430
Employees
43,400
Year Founded
1984

Price Target and Rating

Average Stock Price Forecast
$71.70
High Stock Price Forecast
$98.00
Low Stock Price Forecast
$62.00
Forecasted Upside/Downside
+39.2%
Consensus Rating
Buy
Rating Score (0-4)
3.11
Research Coverage
9 Analysts

Profitability

Net Income
$412.20 million
Pretax Margin
10.34%

Debt

Sales & Book Value

Annual Sales
$5.12 billion
Cash Flow
$7.08 per share
Book Value
$25.07 per share

Miscellaneous

Free Float
97,084,000
Market Cap
$5.28 billion
Optionable
Optionable
Beta
0.91

Social Links


Key Executives














EHC Stock - Frequently Asked Questions

Should I buy or sell Encompass Health stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" EHC shares.
View EHC analyst ratings
or view top-rated stocks.

What is Encompass Health's stock price forecast for 2022?

9 brokerages have issued 12 month price targets for Encompass Health's shares. Their EHC share price forecasts range from $62.00 to $98.00. On average, they predict the company's share price to reach $71.70 in the next twelve months. This suggests a possible upside of 34.9% from the stock's current price.
View analysts price targets for EHC
or view top-rated stocks among Wall Street analysts.

How have EHC shares performed in 2022?

Encompass Health's stock was trading at $65.26 at the beginning of 2022. Since then, EHC stock has decreased by 18.6% and is now trading at $53.15.
View the best growth stocks for 2022 here
.

Are investors shorting Encompass Health?

Encompass Health saw a increase in short interest in July. As of July 31st, there was short interest totaling 2,420,000 shares, an increase of 6.1% from the July 15th total of 2,280,000 shares. Based on an average daily volume of 889,800 shares, the short-interest ratio is presently 2.7 days. Approximately 2.5% of the company's shares are short sold.
View Encompass Health's Short Interest
.

When is Encompass Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our EHC earnings forecast
.

How were Encompass Health's earnings last quarter?

Encompass Health Co. (NYSE:EHC) posted its quarterly earnings data on Monday, August, 1st. The company reported $0.89 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.97 by $0.08. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.34 billion. Encompass Health had a trailing twelve-month return on equity of 16.20% and a net margin of 6.22%. The firm's revenue was up 3.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.17 earnings per share.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Wednesday, July 20th. Shareholders of record on Monday, October 3rd will be paid a dividend of $0.15 per share on Monday, October 17th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date is Friday, September 30th.
Read our dividend analysis for EHC
.

Is Encompass Health a good dividend stock?

Encompass Health (NYSE:EHC) pays an annual dividend of $1.12 per share and currently has a dividend yield of 2.17%. The dividend payout ratio is 34.25%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EHC will have a dividend payout ratio of 33.14% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EHC.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health issued an update on its FY 2022 earnings guidance on Tuesday, August, 9th. The company provided earnings per share (EPS) guidance of $2.77-$2.91 for the period, compared to the consensus EPS estimate of $3.96. The company issued revenue guidance of $4.25 billion-$4.30 billion, compared to the consensus revenue estimate of $5.38 billion.

What is Mark Tarr's approval rating as Encompass Health's CEO?

231 employees have rated Encompass Health Chief Executive Officer Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among the company's employees.

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Salesforce (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Who are Encompass Health's major shareholders?

Encompass Health's stock is owned by many different retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (3.03%), Victory Capital Management Inc. (2.15%), Sumitomo Mitsui Trust Holdings Inc. (1.27%), Brown Advisory Inc. (1.19%), Reinhart Partners Inc. (0.92%) and TimesSquare Capital Management LLC (0.88%). Insiders that own company stock include Andrew L Price, Donald L Correll, Elissa Joy Charbonneau, Kevin J O'connor, Mark J Tarr and Terrance Williams.
View institutional ownership trends
.

How do I buy shares of Encompass Health?

Shares of EHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $53.15.

How much money does Encompass Health make?

Encompass Health (NYSE:EHC) has a market capitalization of $5.30 billion and generates $5.12 billion in revenue each year. The company earns $412.20 million in net income (profit) each year or $3.27 on an earnings per share basis.

How many employees does Encompass Health have?

The company employs 43,400 workers across the globe.

When was Encompass Health founded?

Encompass Health was founded in 1984.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The official website for the company is www.healthsouth.com. The company can be reached via phone at (205) 967-7116, via email at investorrelations@healthsouth.com, or via fax at 205-969-4719.

This page (NYSE:EHC) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.